What is Kyprolis used for?

( ARTG ) Kyprolis is indicated for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior therapy as part of combination therapy with: dexamethasone, or lenalidomide and dexamethasone, or daratumumab and dexamethasone, or isatuximab and dexamethasone

What are the side effects of Kyprolis?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Kyprolis be used during pregnancy?

( AHT ) For the active ingredient carfilzomib You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What precautions should be taken with Kyprolis?

• Caution should be exercised in patients with history of heart arrest, congestive heart failure, high blood pressure, any allergy, who are taking other medications, during pregnancy and breastfeeding. • It may cause fatigue, dizziness, fainting, and/or low blood pressure, do not drive a car or operate machinery while taking this medication. • Patient may experience shortness of breath, if it is so consult with your healthcare provider.

What ATC class does Kyprolis belong to?

Kyprolis: ATC L01XX45. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Kyprolis

INN: carfilzomib

Data updated: 2026-05-02

Available in:

🇩🇪🇬🇧🇫🇷🇵🇹

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Amgen Europe B.V.

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.